search
Back to results

A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction

Primary Purpose

Erectile Dysfunction

Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Levitra (Vardenafil, BAY38-9456)
Placebo
Sponsored by
Bayer
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Erectile Dysfunction focused on measuring Erectile Dysfunction, Vardenafil, Onset of action

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Males with ED for more than 6 months according to the NIH Consensus statement(inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance)
  • Heterosexual relationship
  • 18 years and older

Exclusion Criteria:

  • Primary hypoactive sexual desire
  • History of myocardial infarction, stroke or life threatening arrhythmia within the prior 6 months
  • Nitrates or nitric oxide donors use
  • Other exclusion criteria according to the US Product Information

Sites / Locations

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Arm 1

Arm 2

Arm Description

Outcomes

Primary Outcome Measures

- Earliest elapsed time from dosing to attainment of an erection perceived to be adequate for penetration leading to completion of successful intercourse as measured by Sexual Encounter Profile Question 3 (SEP 3)

Secondary Outcome Measures

- Earliest elapsed time from dosing to attainment of an erection perceived to be adequate for penetration as measured by Sexual Encounter Profile Question 2 (SEP 2).
- The erectile function (EF) domain score of the International Index of Erectile Function (IIEF) calculated as the sum of scores from Questions 1-5 and 15 at Week 4 as well as all other IIEF factor subscores.
- Responder time to onset, where onset is time from dosing to attainment of an erection perceived to be adequate for penetration.
- Other diary questions
- Safety and tolerability

Full Information

First Posted
April 23, 2008
Last Updated
December 15, 2014
Sponsor
Bayer
search

1. Study Identification

Unique Protocol Identification Number
NCT00665496
Brief Title
A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction
Official Title
A Randomized, Double Blind, Double Dummy, Parallel Group, Multi-center Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction.
Study Type
Interventional

2. Study Status

Record Verification Date
December 2014
Overall Recruitment Status
Completed
Study Start Date
June 2003 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
November 2003 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Bayer

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This purpose of the study was to evaluate the earliest time to onset of action in adults with erectile dysfunction (often called impotence). In this study vardenafil has been compared to placebo. Patients were asked to fill in questionnaires and a diary in which they filled in details about attempts at sexual activity during study period. Patients received also a stopwatch to record the time of onset of erection. Stopwatch should be started immediately prior to initiating sexual activity and stopped when an erection perceived to be adequate for penetration was obtained.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Erectile Dysfunction
Keywords
Erectile Dysfunction, Vardenafil, Onset of action

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
732 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Arm 1
Arm Type
Experimental
Arm Title
Arm 2
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Levitra (Vardenafil, BAY38-9456)
Intervention Description
Vardenafil 10 mg and 20 mg orally once a day as needed
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Matching Placebo
Primary Outcome Measure Information:
Title
- Earliest elapsed time from dosing to attainment of an erection perceived to be adequate for penetration leading to completion of successful intercourse as measured by Sexual Encounter Profile Question 3 (SEP 3)
Time Frame
First four doses with successful intercourse
Secondary Outcome Measure Information:
Title
- Earliest elapsed time from dosing to attainment of an erection perceived to be adequate for penetration as measured by Sexual Encounter Profile Question 2 (SEP 2).
Time Frame
among the first four doses
Title
- The erectile function (EF) domain score of the International Index of Erectile Function (IIEF) calculated as the sum of scores from Questions 1-5 and 15 at Week 4 as well as all other IIEF factor subscores.
Time Frame
among the first four doses
Title
- Responder time to onset, where onset is time from dosing to attainment of an erection perceived to be adequate for penetration.
Time Frame
among the first four doses
Title
- Other diary questions
Time Frame
among the first four doses
Title
- Safety and tolerability
Time Frame
within the study duration

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Males with ED for more than 6 months according to the NIH Consensus statement(inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance) Heterosexual relationship 18 years and older Exclusion Criteria: Primary hypoactive sexual desire History of myocardial infarction, stroke or life threatening arrhythmia within the prior 6 months Nitrates or nitric oxide donors use Other exclusion criteria according to the US Product Information
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bayer Study Director
Organizational Affiliation
Bayer
Official's Role
Study Director
Facility Information:
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85023
Country
United States
City
Beverly Hills
State/Province
California
ZIP/Postal Code
90212
Country
United States
City
San Bernardino
State/Province
California
ZIP/Postal Code
92404
Country
United States
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80012
Country
United States
City
Trumbull
State/Province
Connecticut
ZIP/Postal Code
06611
Country
United States
City
Aventura
State/Province
Florida
ZIP/Postal Code
33180
Country
United States
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32257
Country
United States
City
Pembroke Pines
State/Province
Florida
ZIP/Postal Code
33024
Country
United States
City
Lawrenceville
State/Province
New Jersey
ZIP/Postal Code
08648
Country
United States
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28209
Country
United States
City
Wilmington
State/Province
North Carolina
ZIP/Postal Code
28401
Country
United States
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T3G 3J9
Country
Canada
City
Winnipeg
State/Province
Manitoba
ZIP/Postal Code
R3T 5J3
Country
Canada
City
St. John
State/Province
New Brunswick
ZIP/Postal Code
E2L 3J8
Country
Canada
City
Kentville
State/Province
Nova Scotia
ZIP/Postal Code
B4N 4K9
Country
Canada
City
Barrie
State/Province
Ontario
ZIP/Postal Code
L4M 4S5
Country
Canada
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4C 3E7
Country
Canada
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H1T 2M4
Country
Canada
City
Sherbrooke
State/Province
Quebec
ZIP/Postal Code
J1H 5N4
Country
Canada
City
Carpentras
ZIP/Postal Code
84200
Country
France
City
Lille
ZIP/Postal Code
59000
Country
France
City
Lyon Cedex
ZIP/Postal Code
69437
Country
France
City
Lyon
ZIP/Postal Code
69000
Country
France
City
Marseille
ZIP/Postal Code
13275
Country
France
City
Montpellier
ZIP/Postal Code
34000
Country
France
City
Nimes
ZIP/Postal Code
30000
Country
France
City
Paris
ZIP/Postal Code
75015
Country
France
City
Garmisch-Partenkirchen
State/Province
Bayern
ZIP/Postal Code
82467
Country
Germany
City
München
State/Province
Bayern
ZIP/Postal Code
80333
Country
Germany
City
München
State/Province
Bayern
ZIP/Postal Code
81925
Country
Germany
City
Marburg
State/Province
Hessen
ZIP/Postal Code
35039
Country
Germany
City
Hannover
State/Province
Niedersachsen
ZIP/Postal Code
30625
Country
Germany
City
Osnabrück
State/Province
Niedersachsen
ZIP/Postal Code
49076
Country
Germany
City
Westerstede
State/Province
Niedersachsen
ZIP/Postal Code
26655
Country
Germany
City
Düsseldorf
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
40210
Country
Germany
City
Mönchengladbach
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
41061
Country
Germany
City
Niederkassel
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
53859
Country
Germany
City
Halle
State/Province
Sachsen-Anhalt
ZIP/Postal Code
06097
Country
Germany
City
Leipzig
State/Province
Sachsen
ZIP/Postal Code
04105
Country
Germany
City
Hamburg
ZIP/Postal Code
20354
Country
Germany
City
Milano
ZIP/Postal Code
20132
Country
Italy
City
Milano
ZIP/Postal Code
20142
Country
Italy
City
Modena
ZIP/Postal Code
41100
Country
Italy
City
Napoli
ZIP/Postal Code
80131
Country
Italy
City
Padova
ZIP/Postal Code
35128
Country
Italy
City
Amsterdam
ZIP/Postal Code
1061 AE
Country
Netherlands
City
Den Haag
ZIP/Postal Code
2512 VA
Country
Netherlands
City
Nijmegen
ZIP/Postal Code
6525 GA
Country
Netherlands
City
Roermond
ZIP/Postal Code
6043 CV
Country
Netherlands
City
Utrecht
ZIP/Postal Code
3514 AB
Country
Netherlands
City
Moelv
ZIP/Postal Code
2390
Country
Norway
City
Oslo
ZIP/Postal Code
0272
Country
Norway
City
Sarpsborg
ZIP/Postal Code
1700
Country
Norway
City
Trondheim
ZIP/Postal Code
7006
Country
Norway
City
Koscierzyna
ZIP/Postal Code
83-400
Country
Poland
City
Lodz
ZIP/Postal Code
91-425
Country
Poland
City
Poznan
ZIP/Postal Code
61-701
Country
Poland
City
Warszawa
ZIP/Postal Code
01-059
Country
Poland
City
Warszawa
ZIP/Postal Code
04-749
Country
Poland
City
Wroclaw
ZIP/Postal Code
54-144
Country
Poland
City
Badalona
State/Province
Barcelona
ZIP/Postal Code
08916
Country
Spain
City
L'Hospitalet de Llobregat
State/Province
Barcelona
ZIP/Postal Code
08907
Country
Spain
City
Galdakao
State/Province
Bizkaia
ZIP/Postal Code
48960
Country
Spain
City
Barcelona
State/Province
Cataluña
ZIP/Postal Code
08025
Country
Spain
City
Barcelona
ZIP/Postal Code
08003
Country
Spain
City
Castellón de la Plana
ZIP/Postal Code
12004
Country
Spain
City
Madrid
ZIP/Postal Code
28040
Country
Spain
City
Zaragoza
ZIP/Postal Code
50009
Country
Spain
City
Borås
ZIP/Postal Code
503 32
Country
Sweden
City
Göteborg
ZIP/Postal Code
412 59
Country
Sweden
City
Skövde
ZIP/Postal Code
541 30
Country
Sweden
City
Stockholm
ZIP/Postal Code
171 76
Country
Sweden
City
Bristol
State/Province
Avon
ZIP/Postal Code
BS10 5NB
Country
United Kingdom
City
Bristol
State/Province
Avon
ZIP/Postal Code
BS2 8HW
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction

We'll reach out to this number within 24 hrs